Cancer Care Access & Equity: Breaking Barriers to Innovation  

We live in a groundbreaking era of innovation in oncology, yet cancer continues to be the second leading cause of death in the United States. According to the American Cancer Society, there will be over 1.9 million new cancer diagnoses this year and over 600,000 deaths. In addition, cancer care costs the United States a hefty $208 billion each year.  

Many patients are not able to access the benefits of cancer innovations, and too many people – particularly those from historically underserved communities – are without the care they need to survive. To combat the impact of cancer, federal health officials recently introduced initiatives such as the Cancer Moonshot plan, which aims to cut the cancer death rate in half within 25 years. 

What obstacles stand in the way of optimal cancer care? How can we increase cancer screenings, advance research, modernize detection and treatment systems and drive innovation while removing barriers to access and affordability? What role do social determinants of health, like geography and race, play in keeping patients from specialized, life-saving care, and how do we eliminate these disparities?  

The Hill will bring together policymakers, health experts, and patient advocates to discuss the changes to the cancer care delivery system required to bring proven advancements and tomorrow’s life-saving treatments to more patients today. 

Thursday, June 8
2:00 PM ET / 11:00 AM PT

Speakers:

• Dr. Danielle Carnival, Deputy Assistant to the President for the Cancer Moonshot
• Dr. Daniel Derman, SVP of Administration, Northwestern Memorial Hospital 
• Ysabel Duron, President & Executive Director, The Latino Cancer Institute 
• Rep. Brian Higgins (D-NY), Co-Chair, Cancer Caucus; Member, House Ways & Means Committee
• Rep. Mike Kelly (R-PA), Co-Chair, Cancer Caucus; Senior Member, House Ways & Means Committee 
• Dr. Karen Knudsen, CEO, American Cancer Society
• Dr. Lisa Newman, Chief, Breast Surgery Section, Weill Cornell Medicine – New York Presbyterian Hospital

Sponsor Perspective:

• Dr. Harlan Levine, President, Health Innovation and Policy, City of Hope

Moderator:

• Bob Cusack, Editor in Chief, The Hill

Have a question? Tweet us @TheHillEvents
using #TheHillCancerCare

Sponsor:

City of Hope (COH)’s mission is to deliver the cures of tomorrow to the people who need them today. Founded in 1913, COH has grown into one of the largest cancer research and treatment organizations in the U.S. With an independent, National Cancer Institute-Designated Comprehensive Cancer Center at its core, COH brings a uniquely integrated model to patients spanning cancer care, research and development, academics and training, and innovation initiatives. Learn more.